Engel Law PLLC is investigating whether fair value to Amedisys shareholders will result from the proposed merger between Amedisys, Inc. (NASDAQ: AMED) and Option Care Health, Inc., pursuant to which Amedisys stockholders will receive 3.0213 shares of Option Care common stock for each share of Amedisys common stock they hold.
The Firm’s investigation concerns:
(i) whether the Company’s board of directors acted in the best interests of Company shareholders in agreeing to the proposed transaction;
(ii) whether the merger consideration adequately compensates the Company’s shareholders; and
(iii) whether all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed.